AOD-9604 Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References AOD-9604 Peptide Molecular Structure & Chemical Properties AOD-9604 represents a pioneering approach to peptide-based metabolic research, originally developed in the 1990s at Monash University in Australia as a potential anti-obesity therapeutic
Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR
Glucagon-like peptide-1-(936) amide is a major metabolite of glucagon-like peptide-1-(736) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
None of this means a buyer should rush a purchasing decision - but it does mean that the product as currently formulated, priced, and available may not remain in its current form indefinitely
If you need to give yourself a subcutaneous injection, your provider will teach you how to do so